VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by VivoSim Labs, INC. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $2.80K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$2.80K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for VivoSim Labs, INC., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lialin Tony Serge | Chief Commercial Officer | 10,000 | Sep 1, 2026 | 1 |
| Stern Adam K | Director | 19,899 | Jan 29, 2026 | 1 |
| Murphy Keith | EXECUTIVE CHAIRMAN | 26,053 | Jan 29, 2026 | 1 |
| Cohen Douglas Jay | Director | 20,732 | Jan 29, 2026 | 1 |
| Milhous Alison Tjosvold | Director | 19,899 | Jan 29, 2026 | 1 |
| Gobel David | Director | 15,000 | Jan 29, 2026 | 2 |
| Sethi Amar Akhtar | Chief Scientific Officer | – | Nov 26, 2025 | 1 |
| Joshi Vaidehi | Director | 58,821 | Aug 9, 2024 | 0 |
| Jurgensen Thomas E | General Counsel & Secretary | – | Oct 20, 2022 | 0 |
| Miner Jeffrey N. | Chief Scientific Officer | – | Oct 20, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)4:01 PM ET | Aug 31 | 1 day | Lialin Tony SergeChief Commercial Officer | PPurchase | +10.0K | $0.2804 | +$2.80K | New position10.0K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gobel DavidDirector | SSale | +3.27K | $2.24 | +$7.32K | New position0 after | |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Gobel DavidDirector | SSale | −19.6K | $1.62 | −$31.8K | −100.0%0 after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Cohen Douglas JayDirector | PPurchase | +8.75K | $6.72 | +$58.8K | +700.0%10.0K after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Cohen Douglas JayDirector | PPurchase | +2.00K | $6.73 | +$13.5K | New position1.00K after | 2 lots |